AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...

Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on ...

As AstraZeneca floods money into the U.S. market with a wide-ranging investment plan, the company has tapped an in-house ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

If you are wondering whether AstraZeneca shares still offer fair value after a strong run, or if you might be paying too much for the story, this article is designed to help you frame that question ...

On Jan. 4, 2021, a COVID-19 vaccine developed by AstraZeneca and Oxford University was administered for the first time, to an ...

Walmart Inc. will join the Nasdaq 100 Index on January 20, as AstraZeneca exits. This follows Walmart's last year stock ...

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...